Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Neoplasms of the CNS

  Free Subscription


29.10.2018

2 BMC Cancer
3 Br J Neurosurg
1 Cancer
2 Cancer Res
2 Clin Neuropathol
2 Int J Radiat Oncol Biol Phys
1 J Clin Oncol
1 J Neurochem
1 J Neurooncol
2 Neuro Oncol
3 Neurosurgery
3 Oncogene
1 Pediatr Neurosurg
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Cancer

  1. TUNG B, Ma D, Wang S, Oyinlade O, et al
    Kruppel-like factor 9 and histone deacetylase inhibitors synergistically induce cell death in glioblastoma stem-like cells.
    BMC Cancer. 2018;18:1025.
    PubMed     Text format     Abstract available

  2. AIKO N, Shimokawa T, Miyazaki K, Misumi Y, et al
    Comparison of the efficacies of first-generation epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced non-small-cell lung cancer harboring EGFR mutations.
    BMC Cancer. 2018;18:1012.
    PubMed     Text format     Abstract available


    Br J Neurosurg

  3. AKBARI H, Malek M, Ghorbani M, Ramak Hashemi SM, et al
    Clinical outcomes of endoscopic versus microscopic trans-sphenoidal surgery for large pituitary adenoma.
    Br J Neurosurg. 2018;32:206-209.
    PubMed     Text format     Abstract available

  4. ADELEYE AO
    Low rates of post-craniotomy surgical site infections in a developing country: surgical technique and results.
    Br J Neurosurg. 2017 Nov 24:1-5. doi: 10.1080/02688697.2017.1407746.
    PubMed     Text format     Abstract available

  5. QUICK-WELLER J, Brawanski N, Dinc N, Behmanesh B, et al
    Stereotactic biopsy of cerebellar lesions: straight versus oblique frame positioning.
    Br J Neurosurg. 2018;32:210-213.
    PubMed     Text format     Abstract available


    Cancer

  6. MARAKA S, Groves MD, Mammoser AG, Melguizo-Gavilanes I, et al
    Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma.
    Cancer. 2018 Oct 25. doi: 10.1002/cncr.31811.
    PubMed     Text format     Abstract available


    Cancer Res

  7. AASLAND D, Gotzinger L, Hauck L, Berte N, et al
    Temozolomide induces senescence and repression of DNA repair pathways in glioblastoma cells via activation of ATR-CHK1, p21, and NF-kB.
    Cancer Res. 2018 Oct 25. pii: 0008-5472.CAN-18-1733.
    PubMed     Text format     Abstract available

  8. ALMIRON BONNIN DA, Havrda MC, Israel MA
    Glioma Cell Secretion: A Driver of Tumor Progression and a Potential Therapeutic Target.
    Cancer Res. 2018 Oct 17. pii: 0008-5472.CAN-18-0345.
    PubMed     Text format     Abstract available


    Clin Neuropathol

  9. JOHNSON KJ, Broholm H, Scheurer ME, Lau CC, et al
    Advancing brain tumor epidemiology - multilevel integration and international collaboration: The 2018 Brain Tumor Epidemiology Consortium meeting report.
    Clin Neuropathol. 2018 Oct 22. pii: 17720. doi: 10.5414/NP301148.
    PubMed     Text format     Abstract available

  10. KLOTZ S, Matula C, Pones M, Herac M, et al
    Clinical Neuropathology image 6-2018: Metastasis of breast carcinoma to meningioma.
    Clin Neuropathol. 2018 Oct 22. pii: 17721. doi: 10.5414/NP301150.
    PubMed     Text format    


    Int J Radiat Oncol Biol Phys

  11. PENG L, Parekh V, Huang P, Lin DD, et al
    Distinguishing True Progression From Radionecrosis After Stereotactic Radiation Therapy for Brain Metastases With Machine Learning and Radiomics.
    Int J Radiat Oncol Biol Phys. 2018;102:1236-1243.
    PubMed     Text format     Abstract available

  12. SMITH SMC, Bianski BM, Orr BA, Harknett G, et al
    Preclinical Modeling of Image-Guided Craniospinal Irradiation for Very-High-Risk Medulloblastoma.
    Int J Radiat Oncol Biol Phys. 2018 Oct 23. pii: S0360-3016(18)33898.
    PubMed     Text format     Abstract available


    J Clin Oncol

  13. KALEY T, Touat M, Subbiah V, Hollebecque A, et al
    BRAF Inhibition in BRAF(V600)-Mutant Gliomas: Results From the VE-BASKET Study.
    J Clin Oncol. 2018 Oct 23:JCO2018789990. doi: 10.1200/JCO.2018.78.9990.
    PubMed     Text format     Abstract available


    J Neurochem

  14. KHANI P, Nasri F, Khani Chamani F, Saeidi F, et al
    Genetic and epigenetic contribution to astrocytic gliomas pathogenesis.
    J Neurochem. 2018 Oct 22. doi: 10.1111/jnc.14616.
    PubMed     Text format     Abstract available


    J Neurooncol

  15. BAGLEY SJ, Hwang WT, Brem S, Linette GP, et al
    RNA-seq for identification of therapeutically targetable determinants of immune activation in human glioblastoma.
    J Neurooncol. 2018 Oct 23. pii: 10.1007/s11060-018-03010.
    PubMed     Text format     Abstract available


    Neuro Oncol

  16. JOHN F, Bosnyak E, Robinette NL, Amit-Yousif AJ, et al
    Multimodal Imaging-defined Subregions in Newly-diagnosed Glioblastoma: Impact on Overall Survival.
    Neuro Oncol. 2018 Oct 22. pii: 5140157. doi: 10.1093.
    PubMed     Text format     Abstract available

  17. DIPLAS BH, Liu H, Yang R, Hansen LJ, et al
    Sensitive and rapid detection of TERT promoter and IDH mutations in diffuse gliomas.
    Neuro Oncol. 2018 Oct 22. pii: 5140128. doi: 10.1093.
    PubMed     Text format     Abstract available


    Neurosurgery

  18. PRESS RH, Zhang C, Chowdhary M, Prabhu RS, et al
    Hemorrhagic and Cystic Brain Metastases Are Associated With an Increased Risk of Leptomeningeal Dissemination After Surgical Resection and Adjuvant Stereotactic Radiosurgery.
    Neurosurgery. 2018 Oct 17. pii: 5134279. doi: 10.1093.
    PubMed     Text format     Abstract available

  19. UDELSMAN BV, Jones PS, Bababekov YJ, Carter BS, et al
    Commentary: Predicting Inpatient Length of Stay After Brain Tumor Surgery: Developing Machine Learning Ensembles to Improve Predictive Performance.
    Neurosurgery. 2018 Oct 17. pii: 5134277. doi: 10.1093.
    PubMed     Text format    

  20. GUTT-WILL M, Murek M, Schwarz C, Hewer E, et al
    Frequent Diagnostic Under-Grading in Isocitrate Dehydrogenase Wild-Type Gliomas due to Small Pathological Tissue Samples.
    Neurosurgery. 2018 Oct 17. pii: 5134283. doi: 10.1093.
    PubMed     Text format     Abstract available


    Oncogene

  21. ZEPECKI JP, Snyder KM, Moreno MM, Fajardo E, et al
    Regulation of human glioma cell migration, tumor growth, and stemness gene expression using a Lck targeted inhibitor.
    Oncogene. 2018 Oct 23. pii: 10.1038/s41388-018-0546.
    PubMed     Text format     Abstract available

  22. BAKHSHINYAN D, Venugopal C, Adile AA, Garg N, et al
    BMI1 is a therapeutic target in recurrent medulloblastoma.
    Oncogene. 2018 Oct 22. pii: 10.1038/s41388-018-0549.
    PubMed     Text format     Abstract available

  23. LIU X, Bao Y, Meng W, Yang P, et al
    TROY interacts with RKIP to promote glioma development.
    Oncogene. 2018 Oct 18. pii: 10.1038/s41388-018-0503.
    PubMed     Text format     Abstract available


    Pediatr Neurosurg

  24. GUILLEN QUESADA A, Puerta Roldan P, Morales la Madrid A, Sunol M, et al
    Diffuse Leptomeningeal Glioneural Tumour Simulating Tuberculous Meningitis in a 13-Year-Old Girl.
    Pediatr Neurosurg. 2018;53:140-142.
    PubMed     Text format    


    PLoS One

  25. ARNLI MB, Winther TL, Lydersen S, Torp SH, et al
    Prognostic value of ErbB2/HER2 in human meningiomas.
    PLoS One. 2018;13:e0205846.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: